Tcr2 Therapeutics Inc.

CIK 1750019 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tcr2 Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 202440001415889-24-003784
Feb 14, 2024SC 13G/A0001214659-24-002881
Jun 12, 202315-12G0001104659-23-070143
Jun 5, 2023EFFECT9999999995-23-001627
Jun 5, 2023EFFECT9999999995-23-001625
Jun 5, 202340001209191-23-034340
Jun 5, 202340001209191-23-034346
Jun 5, 202340001209191-23-034336
Jun 5, 202340001209191-23-034343
Jun 5, 2023EFFECT9999999995-23-001626
Jun 1, 2023POS AM0001104659-23-067103
Jun 1, 202325-NSE0001354457-23-000372
Jun 1, 202340001104659-23-067056
Jun 1, 202340001104659-23-067053
Jun 1, 2023S-8 POS0001104659-23-067098
Jun 1, 2023POS AM0001104659-23-067104
Jun 1, 20238-K0001104659-23-067031
Jun 1, 202340001104659-23-067078
Jun 1, 202340001104659-23-067048
Jun 1, 2023S-8 POS0001104659-23-067095
Jun 1, 202340001104659-23-067057
Jun 1, 202340001104659-23-067075
Jun 1, 2023S-8 POS0001104659-23-067092
Jun 1, 202340001104659-23-067064
Jun 1, 202340001104659-23-067068